within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A08A_AntiobesityPreparationsExclDietProducts.A08AA02_Fenfluramine;

model Fenfluramine
  extends Pharmacolibrary.Drugs.ATC.A.A08AA02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A08AA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Fenfluramine is an amphetamine derivative previously used as an appetite suppressant for the treatment of obesity. It acts as a serotonin-releasing agent. Due to its association with pulmonary hypertension and heart valve disease, fenfluramine was withdrawn from the market in most countries in the late 1990s. It has been re-approved in some regions for the treatment of Dravet syndrome, a rare form of epilepsy, under the branded name Fintepla.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult volunteers after oral administration; typical therapeutic dose.</p><h4>References</h4><ol><li><p> (2024). Comparison Table: Some oral antiseizure medications. <i>The Medical letter on drugs and therapeutics</i> 66(1708) e133–e140. DOI:<a href=\"https://doi.org/10.58347/tml.2024.1708b\">10.58347/tml.2024.1708b</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39073881/\">https://pubmed.ncbi.nlm.nih.gov/39073881</a></p></li><li><p>Gammaitoni, A, et al., &amp; Boyd, B (2018). The Lack of Effect of Food on the Pharmacokinetics of ZX008 (Fenfluramine Oral Solution): Results of a Single-dose, Two-period Crossover Study. <i>Clinical therapeutics</i> 40(8) 1338–1346. DOI:<a href=\"https://doi.org/10.1016/j.clinthera.2018.05.013\">10.1016/j.clinthera.2018.05.013</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29941151/\">https://pubmed.ncbi.nlm.nih.gov/29941151</a></p></li><li><p>Mittur, A, et al., &amp; Boyd, B (2024). Effect of Hepatic Impairment on the Pharmacokinetics of Fenfluramine and Norfenfluramine. <i>Journal of clinical pharmacology</i> 64(7) 887–898. DOI:<a href=\"https://doi.org/10.1002/jcph.2431\">10.1002/jcph.2431</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38523492/\">https://pubmed.ncbi.nlm.nih.gov/38523492</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Fenfluramine;
